Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells

Abstract

tHMSN might serve as an effective active targeting nanocarrier strategy for anti-mammary cancer drug delivery.